Bunkerhill AVC

by Bunkerhill Health  · Based in United States → — The Long-Horizon AI Agent for Health Systems
Cardiology Radiology

Regulatory Status Disclosed

Overview

Bunkerhill Health is a pioneering healthcare technology company dedicated to transforming patient care through artificial intelligence. Its flagship platform, Carebricks, is a generative AI platform for clinical reasoning and action. Carebricks analyzes structured and unstructured patient data from electronic health records (EHRs) and clinical archives to understand each patient’s full history, apply AI-powered reasoning, surface insights, and automate appropriate next steps.

While the user prompt mentions “Bunkerhill AVC” for a “physician directory,” Bunkerhill AVC is specifically an AI algorithm within the broader Carebricks platform. This assists physicians, particularly radiologists and cardiologists, in the early detection and proactive management of calcific aortic valve disease and aortic stenosis.

Bunkerhill Health’s solutions aim to bridge the gap between AI’s potential and its real-world clinical impact by enabling health systems to design and deploy AI-powered, end-to-end workflows across various specialties and use cases, improving care and efficiency without adding clinician workload.

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Key Features

  • Generative AI for clinical reasoning and action
  • Automated detection and quantification of aortic valve calcification (Bunkerhill AVC)
  • Automated detection and quantification of coronary artery calcification (iCAC, Contrast CAC)
  • Automated detection and quantification of mitral annular calcification (Bunkerhill MAC)
  • Opportunistic bone density assessment (Bunkerhill BMD)
  • Integration with Electronic Health Records (EHRs) and clinical archives
  • Customizable AI agents for diverse workflows
  • Natural language processing for patient record interaction (Carebricks Chat)
  • Continuous patient monitoring and identification of care opportunities
  • Automated next steps (e.g., referrals, orders, documentation, patient notifications)

Use Cases

  • Incidental pulmonary nodule management
  • Cardiovascular risk identification and follow-up
  • Prior authorization automation
  • Chronic kidney disease care gap closure
  • Peri-operative medical clearance automation
  • Case documentation improvement support

What Physicians Need to Know

ECG/EKG Analysis Capability
Bunkerhill Health offers an FDA-cleared AI algorithm, ECG-EF, which detects reduced left ventricular ejection fraction (LVEF) from routine 12-lead electrocardiograms (ECGs). This serves as a key indicator of heart failure and allows for earlier flagging of high-risk patients.
Cardiac CT/MRI Analysis
Bunkerhill AVC is an FDA-cleared software device that detects and quantifies aortic valve calcification (AVC) in adult patients aged 40 and above. It analyzes non-gated, non-contrast, and contrast-enhanced chest CT images. The platform also includes Bunkerhill Contrast CAC for detecting and quantifying coronary artery calcium (CAC) on contrast-enhanced CT scans, and Bunkerhill MAC for detecting and evaluating mitral annular calcification on routine, non-gated CT scans. These algorithms allow for opportunistic detection of cardiovascular disease from CT scans performed for other medical reasons.
Heart Failure Risk Prediction
The ECG-EF algorithm aids in screening for Left Ventricular Ejection Fraction (LVEF) less than or equal to 40%, which is a significant indicator of heart failure risk.
Coronary Artery Assessment
Bunkerhill Contrast CAC is an FDA-cleared AI algorithm designed to detect and quantify coronary artery calcium (CAC) on both non-contrast and contrast-enhanced, non-gated chest CT scans. This enables automated identification and quantification of these findings on scans patients already receive as part of routine care.
AHA/ACC Guideline Alignment
The American College of Radiology recommends reporting incidental findings such as moderate or greater aortic valve calcification, aligning with Bunkerhill AVC's capabilities. The platform also supports guideline-aligned cardiology follow-up.
Real-Time Alert Capability
Bunkerhill's Carebricks platform enables AI agents to automate next steps, such as notifying care teams and routing referrals, and provides instant, actionable insights for CAC and AVC scores, suggesting real-time or near real-time alert capabilities for actionable findings.
Physician Tip

Bunkerhill AVC and its related algorithms (Bunkerhill Contrast CAC, Bunkerhill MAC, ECG-EF) are designed to leverage existing imaging and ECG data to opportunistically detect cardiovascular conditions like aortic valve calcification, coronary artery calcification, and reduced left ventricular ejection fraction. This can help identify at-risk patients who might otherwise be missed, enabling earlier intervention and proactive management. The output is intended for informational purposes and should be used by qualified medical professionals in conjunction with their standard workflow. Further action on a patient should only be taken at the recommendation of a physician after reviewing all patient results. The Carebricks platform can automate workflows, including notifications and referrals, to streamline follow-up care.

Bunkerhill AVC is a software as a medical device (SaMD) that interfaces with compatible and commercially available computed tomography (CT) systems. The algorithms are available within Bunkerhill's AI platform, Carebricks, which integrates various clinical AI models into standard workflows. Carebricks enables AI-powered workflows that analyze patient records, clinical guidelines, and care protocols, supporting chart review, determining follow-up eligibility, and guiding next steps in care. The platform can also automate downstream tasks like orders, coding queries, prior authorization submissions, and can integrate with EHRs and ERPs.

Details

Category Cardiology AI, Clinical Decision Support & Reference
Pricing Unknown
Compliance
BAA Available Yes AI-estimated
HIPAA Compliant Yes AI-estimated
FDA Status Cleared AI-estimated
SOC 2 Yes AI-estimated
Integrations
EHR Not specified
Specialties Cardiology, Radiology

FDA clearance history

This product’s FDA authorization. From FDA’s list of AI-enabled medical devices; each number links to FDA’s record.

Decision dateNumberName as listed by FDA
2025-01-27K243229 510(k)Bunkerhill AVC

Ratings & Reviews

No reviews yet. Be the first to review this tool!

Rate Bunkerhill AVC

Clinical Value
Ease of Use
Integration
Support & Docs
Value for Money
No press coverage or publications on file yet. Know of some? Suggest an edit →

Videos

Product demos, reviews, and walkthroughs for Bunkerhill AVC.

View all on YouTube

Frequently Asked Questions

Bunkerhill AVC is an AI solution that detects and quantifies aortic valve calcification (AVC) from non-gated, non-contrast chest CT images. It assists cardiologists by providing early detection of calcific aortic valve disease, which can lead to proactive disease management and potentially improved patient outcomes.
Yes, Bunkerhill AVC is FDA-cleared. It is intended for use in detecting the presence and estimating the quantity of aortic valve calcification in adult patients aged 40 years and above. The device automatically analyzes routine CT images and provides quantification of detected calcium, which is intended to aid the physician during review.
Bunkerhill AVC is designed to integrate into a physician's standard workflow, making its output available on-demand. It can be viewed within Bunkerhill's Carebricks AI platform, which allows health systems to build and deploy AI agents for various clinical and operational tasks, including initiating referrals and coordinating follow-up care.
Bunkerhill AVC is not intended to be used as a standalone diagnostic tool. The results are solely meant to aid and provide information to the physician, and any further action taken on a patient should only come at the recommendation of the physician after a comprehensive review of the patient's results.
Yes, the Centers for Medicare and Medicaid Services (CMS) has established a national billing code (G0680) and associated payment under the Hospital Outpatient Prospective Payment System (OPPS) for algorithmic analysis of coronary artery calcium (CAC) and aortic valve calcium (AVC) on chest CT scans, effective April 1, 2026.

Related Tools

Stethophone Pro
Sparrow Acoustics
Cardiology AI
Stethophone Pro transforms smartphones into advanced cardiac screening tools, enabling clinicians to capture, interpret, and visualize heart sounds for early detection of cardiovascular diseases.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System, ACUSON Origin ICE Diagnostic Ultrasound System
Siemens Medical Solutions, USA
Cardiology AI
Siemens Healthineers offers advanced AI-powered ultrasound systems, including the ACUSON Origin for comprehensive cardiovascular care and the ACUSON Sequoia for high-performance general imaging with BioAcoustic™ technology.
syngo.via MI Workflows, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, syngo MBF is an intelligent, integrated imaging software that helps address the challenges of interpreting, managing, and sharing complex data from molecular imaging scanners, providing automated workflows and advanced visualization for various clinical applications.
syngo.via MI WorkFlows, Scenium, syngo MBF
Siemens Medical Solutions USA
Cardiology AI
syngo.via MI Workflows, Scenium, and syngo MBF are medical diagnostic post-processing applications for viewing, manipulation, quantification, analysis, and comparison of PET or nuclear-medicine functional data with CT or MR anatomical data across timepoints, supporting disease management and radiotherapy treatment planning by trained healthcare professionals.
ACUSON Sequoia Diagnostic Ultrasound System, ACUSON Sequoia Select Diagnostic Ultrasound System, ACUSON Origin Diagnostic Ultrasound System
Siemens Medical Solutions USA
Cardiology AI
Siemens Healthineers offers the ACUSON Sequoia, ACUSON Sequoia Select, and ACUSON Origin ultrasound systems, providing advanced imaging for various medical needs. The Sequoia line focuses on high-resolution imaging with deep penetration and reduced variability, while the AI-powered ACUSON Origin specializes in comprehensive cardiovascular diagnostics and interventions.
R30 Diagnostic Ultrasound System
Samsung Medison Co.
Cardiology AI
The Samsung Medison R30 Diagnostic Ultrasound System is a general-purpose, mobile, software-controlled diagnostic ultrasound system that offers a wide range of imaging capabilities and analysis tools for various clinical applications.

See all Cardiology AI tools →

More from Bunkerhill Health

Bunkerhill Abdominal Aortic Quantification (AAQ)
Bunkerhill Health
Cardiology AI
BunkerHill BMD
Bunkerhill Health
Endocrinology & Metabolic AI
Bunkerhill Contrast AVC
BunkerHill Health
Clinical Decision Support & Reference
Bunkerhill Health offers an AI-powered platform, Carebricks, that provides agentic AI infrastructure for hospitals and health systems, automating clinical reasoning and workflows.
Bunkerhill Contrast CAC
BunkerHill Health
Clinical Decision Support & Reference
Bunkerhill Health offers an AI platform called Carebricks that allows health systems to deploy AI agents for clinical reasoning and action, automating tasks and surfacing actionable insights from patient data.

View company profile →

Suggest an Edit → | Report an issue | Last Verified: 2026-11-03 | First Added: 2026-04-17
AI Tool Finder
AI-powered search. Results may not be comprehensive.